Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
d decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1321
-
1322
-
1323
-
1324
-
1325
-
1326
-
1327
Decreased projections to LP in <i>Brn3b</i> mutants occur postnatally.
Published 2023“…(Right) Magnified view of the boxed areas showing the LP regions used for analysis. (<b>D</b>) Quantification was presented as a relative difference between the AP-covered LP area in controls and mutants (1.00 ± 0.07 for control, 0.20 ± 0.03 for cKO; <i>n</i> = 4 mice/group). …”
-
1328
-
1329
-
1330
-
1331
Laquinimod prevents EAE and decreases encephalitogenicity of T cells.
Published 2012“…<p>DBA/1 (A) mice and C57BL/6 mice (B) were treated daily with laquinimod (25 mg/kg, n = 6/group) or vehicle (water, n = 6/group) starting from the day of immunization with rMOG 1-125 (DBA/1) or MOG p35-55 (C57BL/6). …”
-
1332
-
1333
Cediranib therapy decreases tumor blood volume.
Published 2013“…<p>(left) After 2–3 days of treatment, a statistically significant (p<0.01) difference in the rCBV (±SEM) was observed between cediranib and control groups with a 16.5±2.2% decrease for cediranib treated animals and a 14.1±2.3% increase for control animals. …”
-
1334
-
1335
-
1336
-
1337
-
1338
VHFD becomes dehydrated, decreasing its palatability.
Published 2023“…(C) Dehydrating VHFD decreased preference to consume it. (D) Rehydrating VHFD improved preference to consume 1, 2, or 3-day old VHFD but not 4, 5, 6, or 7-day old VHFD. …”
-
1339
Decreased function of Nrf2 in the aging heart.
Published 2013“…(<b>C</b>) <b>Localization of Nrf2 by immunofluorescence:</b> Immunofluorescence analysis using anti-Nrf2-ab (1∶200; v/v) showing decreased cytosolic and nuclear Nrf2 in old versus young myocardium. …”
-
1340